Behind all the hype and hoopla about biosimilars
Looking at the pipeline of biosimilars, India shall remain a major market for biosimilars. Dr Siddharth Dutta, Associate Vice…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Bayer, J&J’s heart drug Xarelto fails trial to widen use
The blockbuster clot prevention drug could not be shown to reduce the rate of dangerous blood clots in a certain group of…
Good medicines come in quality packages
In the third of a series of six articles, Organisation of Pharmaceutical Producers of India (OPPI) launches the Know Your Pill…
Pfizer, Astellas revise two cancer drug trial protocols to speed up results
Both trials are testing Xtandi in men with hormone-sensitive prostate cancer
Moderate ‘bad cholesterol’ levels tied to early death for healthy people
Researchers examined data on 36,375 adults with no history of heart disease or diabetes and a low 10-year risk for events like…
Staying fit might cut glaucoma risk: Study
The study was not designed to determine whether or how exercise or physical fitness may directly influence glaucoma risk
Registration brochure of 70th IPC released
Sponsorship opportunities brochure and advertisement-cum-souvenir brochure were released by other group of members
Earlier onset of type 1 diabetes linked to greater heart risk, shorter life
27,195 individuals aged 18 years and older in the Swedish National Diabetes Register who had been diagnosed with type 1 diabetes…
CPhI annual report expert warns innovation is being hindered by regulators
Girish Malhotra sees CDMOs as potentially a source of process innovation but warns both regulator and license holders need to move…